These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3141113)
1. Bone lead and the diagnosis of lead nephropathy. Wedeen RP; Van de Vyver FL; D'Haese PC; Visser WJ; Elseviers MM; Knippenberg LJ; Lamberts LV; De Broe ME; Batuman V; Schidlovsky G Contrib Nephrol; 1988; 64():102-8. PubMed ID: 3141113 [No Abstract] [Full Text] [Related]
2. Chronic lead nephropathy in Queensland: alternative methods of diagnosis. Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647 [TBL] [Abstract][Full Text] [Related]
3. Bone lead, hypertension, and lead nephropathy. Wedeen RP Environ Health Perspect; 1988 Jun; 78():57-60. PubMed ID: 3203647 [TBL] [Abstract][Full Text] [Related]
4. Lead and the gouty kidney. Wedeen R Am J Kidney Dis; 1983 Mar; 2(5):559-63. PubMed ID: 6402928 [No Abstract] [Full Text] [Related]
5. Laboratory diagnosis of increased lead absorption. Baloh RW Arch Environ Health; 1974 Apr; 28(4):198-208. PubMed ID: 4205503 [No Abstract] [Full Text] [Related]
6. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores. Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094 [TBL] [Abstract][Full Text] [Related]
7. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study. Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468 [TBL] [Abstract][Full Text] [Related]
9. The role of lead in gout nephropathy. Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160 [No Abstract] [Full Text] [Related]
10. L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications. Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN Proc Natl Acad Sci U S A; 1989 Jan; 86(2):685-9. PubMed ID: 2492111 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of experimental subclinical lead poisoning in sheep]. Prigge E; Hapke HJ Dtsch Tierarztl Wochenschr; 1972 Oct; 79(19):475-6 passim. PubMed ID: 4565151 [No Abstract] [Full Text] [Related]
12. Failure of chelation therapy in lead nephropathy. Germain MJ; Braden GL; Fitzgibbons JP Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141 [TBL] [Abstract][Full Text] [Related]
14. Lead nephropathy. Wedeen RP; D'Haese P; Van de Vyver FL; Verpooten GA; De Broe ME Am J Kidney Dis; 1986 Nov; 8(5):380-3. PubMed ID: 3098095 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of lead poisoning. Wynchank S; Selby P; Ehrlich R; Todd AC Presse Med; 1994 Nov; 23(36):1670. PubMed ID: 7899297 [No Abstract] [Full Text] [Related]
16. Chronic renal failure with gout: a marker of chronic lead poisoning. Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW Kidney Int; 1984 Sep; 26(3):319-23. PubMed ID: 6439940 [TBL] [Abstract][Full Text] [Related]